Depression, anxiety and 6-year risk of cardiovascular disease

Journal of Psychosomatic Research

Volumn 78, Issue 2, 2015, Pages 123-129

  Seldenrijk, Adrie ^a   Vogelzangs, Nicole ^a   Batelaan, Neeltje M ^a   Wieman, Iris ^a   van Schaik, Digna J F ^a   Penninx, Brenda J W H ^a,b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anxiety disorders; Cardiovascular diseases; Depressive disorders

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DSM-IV; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NETHERLANDS; SELF REPORT; ANXIETY; ANXIETY DISORDERS; CARDIOVASCULAR DISEASES; COMPLICATION; DEPRESSIVE DISORDER; INCIDENCE; MIDDLE AGED; PERSONALITY TEST; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; QUESTIONNAIRE; RISK; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; ANXIETY; ANXIETY DISORDERS; BENZODIAZEPINES; CARDIOVASCULAR DISEASES; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PERSONALITY INVENTORY; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SELF REPORT; SEVERITY OF ILLNESS INDEX;

EID: 84920923295     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2014.10.007     Document Type: Article

References (58)

1. Mathers CD, Loncar D Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
2. Roest AM, Martens EJ, de Jonge P, Denollet J Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010, 56:38-46.
3. Nicholson A, Kuper H, Hemingway H Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006, 27:2763-2774.
4. De Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002, 159:620-629.
5. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry 1996, 17-30.
6. Brown JM, Stewart JC, Stump TE, Callahan CM Risk of coronary heart disease events over 15years among older adults with depressive symptoms. Am J Geriatr Psychiatry 2011, 19:721-729.
7. Rowan PJ, Haas D, Campbell JA, Maclean DR, Davidson KW Depressive symptoms have an independent, gradient risk for coronary heart disease incidence in a random, population-based sample. Ann Epidemiol 2005, 15:316-320.
8. Sesso HD, Kawachi I, Vokonas PS, Sparrow D Depression and the risk of coronary heart disease in the Normative Aging Study. Am J Cardiol 1998, 82:851-856.
9. Shen BJ, Avivi YE, Todaro JF, Spiro A, Laurenceau JP, Ward KD, et al. Anxiety characteristics independently and prospectively predict myocardial infarction in men the unique contribution of anxiety among psychologic factors. J Am Coll Cardiol 2008, 51:113-119.
10. Cohen HW, Gibson G, Alderman MH Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000, 108:2-8.
11. Hamer M, David BG, Seldenrijk A, Kivimaki M Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J 2011, 32:437-442.
12. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 2009, 169:2128-2139.
13. Honkola J, Hookana E, Malinen S, Kaikkonen KS, Junttila MJ, Isohanni M, et al. Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J 2012, 33:745-751.
14. Lapane KL, Zierler S, Lasater TM, Barbour MM, Carleton R, Hume AL Is the use of psychotropic drugs associated with increased risk of ischemic heart disease?. Epidemiology 1995, 6:376-381.
15. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996, 94:3123-3129.
16. Bijl RV, Ravelli A, van Zessen G Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998, 33:587-595.
17. Landman-Peeters KM, Hartman CA, van der Pompe G, den Boer JA, Minderaa RB, Ormel J Gender differences in the relation between social support, problems in parent-offspring communication, and depression and anxiety. Soc Sci Med 2005, 60:2549-2559.
18. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008, 17:121-140.
19. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2001, Amer Psychiatric Pub, Washington, DC, [4th edition]. 4th ed.
20. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Brit J Psychiatry 1991, 159:645-653. (658).
21. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996, 26:477-486.
22. Beck AT, Epstein N, Brown G, Steer RA An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
23. Marks IM, Mathews AM Brief standard self-rating for phobic patients. Behav Res Ther 1979, 17:263-267.
24. Meyer TJ, Miller ML, Metzger RL, Borkovec TD Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990, 28:487-495.
25. Brown TA Confirmatory factor analysis of the Penn State Worry Questionnaire: multiple factors or method effects?. Behav Res Ther 2003, 41:1411-1426.
26. Fresco DM, Heimberg RG, Mennin DS, Turk CL Confirmatory factor analysis of the Penn State Worry Questionnaire. Behav Res Ther 2002, 40:313-323.
27. WHO Collaborating Centre for Drug Statistics Methodology Anatomical Therapeutic Chemical Classification 2007, World Health Organization, Geneva.
28. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
29. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011, 306:1241-1249.
30. Gustad LT, Laugsand LE, Janszky I, Dalen H, Bjerkeset O Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study. Eur Heart J 2014, 35:1394-1403.
31. Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study. J Affect Disord 2013, 150:84-90.
32. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med 2007, 69:323-331.
33. Meyer T, Buss U, Herrmann-Lingen C Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med 2010, 72:9-15.
34. Janszky I, Ahnve S, Lundberg I, Hemmingsson T Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol 2010, 56:31-37.
35. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression 1. Biol Psychiatry 2010, 67:446-457.
36. Stetler C, Miller GE Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research 1. Psychosom Med 2011, 73:114-126.
37. von Kanel R, Mills PJ, Fainman C, Dimsdale JE Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?. Psychosom Med 2001, 63:531-544.
38. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis 1. Biol Psychiatry 2010, 67:1067-1074.
39. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies 1. Diabetes Care 2012, 35:1171-1180.
40. Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease 2. Atherosclerosis 2005, 178:339-344.
41. Aberg MA, Waern M, Nyberg J, Pedersen NL, Bergh Y, Aberg ND, et al. Cardiovascular fitness in males at age 18 and risk of serious depression in adulthood: Swedish prospective population-based study. Brit J Psychiatry 2012, 201:352-359.
42. Tham MW, Woon PS, Sum MY, Lee TS, Sim K White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies 14. J Affect Disord 2011, 132:26-36.
43. Lopez-Leon S, Aulchenko YS, Tiemeier H, Oostra BA, van Duijn CM, Janssens AC Shared genetic factors in the co-occurrence of symptoms of depression and cardiovascular risk factors 1. J Affect Disord 2010, 122:247-252.
44. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011, 32:1484-1492.
45. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep 2011, 34:1487-1492.
46. Manthey L, Giltay EJ, van Veen T, Neven AK, Zitman FG, Penninx BW Determinants of initiated and continued benzodiazepine use in the Netherlands study of depression and anxiety. J Clin Psychopharmacol 2011, 31:774-779.
47. Windle M, Windle RC Recurrent depression, cardiovascular disease, and diabetes among middle-aged and older adult women. J Affect Disord 2013, 150:895-902.
48. Baune BT, Adrian I, Arolt V, Berger K Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychother Psychosom 2006, 75:319-326.
49. Chen YH, Tsai SY, Lee HC, Lin HC Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosom Med 2009, 71:798-804.
50. Gomez-Caminero A, Blumentals WA, Russo LJ, Brown RR, Castilla-Puentes R Does panic disorder increase the risk of coronary heart disease? A cohort study of a national managed care database. Psychosom Med 2005, 67:688-691.
51. Batelaan NM, ten Have M, van Balkom AJ, Tuithof M, de Graaf R Anxiety disorders and onset of cardiovascular disease: the differential impact of panic, phobias and worry. J Anxiety Disord 2014, 28:252-258.
52. Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry 2007, 64:1153-1160.
53. Kubzansky LD, Kawachi I, Spiro A, Weiss ST, Vokonas PS, Sparrow D Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997, 95:818-824.
54. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005, 111:480-487.
55. Haines AP, Imeson JD, Meade TW Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) 1987, 295:297-299.
56. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994, 89:1992-1997.
57. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996, 49:1407-1417.
58. Skinner KM, Miller DR, Lincoln E, Lee A, Kazis LE Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambul Care Manage 2005, 28:102-110.